The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection.
The statin family of cholesterol-lowering drugs is known to have pleiotropic properties which include anti-inflammatory and immunomodulatory effects. Statins exert their pleiotropic effects by altering expression of human immune regulators including pro-inflammatory cytokines. Previously we found th...
Guardado en:
Autores principales: | Emma Hennessy, Julie O'Callaghan, Marlies J Mooij, Claire Legendre, Olga Camacho-Vanegas, Sandra C Camacho, Claire Adams, John A Martignetti, Fergal O'Gara |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/21193d5fc4c94b3cbef819c9f1935b9f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A non-classical LysR-type transcriptional regulator PA2206 is required for an effective oxidative stress response in Pseudomonas aeruginosa.
por: F Jerry Reen, et al.
Publicado: (2013) -
Respiratory pathogens adopt a chronic lifestyle in response to bile.
por: F Jerry Reen, et al.
Publicado: (2012) -
<italic toggle="yes">Pseudomonas aeruginosa</italic> Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease
por: Jessica L. Bradshaw, et al.
Publicado: (2018) -
Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa
por: Megan Y. Nas, et al.
Publicado: (2021) -
Effects of simvastatin on bleomycin-induced pulmonary fibrosis in female rats
por: Tulek,Baykal, et al.
Publicado: (2012)